Showing results (91-100 of 626) with videos related to

Sort By:
Pageof 63
Future Oncology (London, England)|March 17, 2021
Poly(ADP-ribose) polymerase inhibitors in combination with anti-angiogenic agents for the treatment of advanced ovarian cancerOlivia Le Saux, Hélène Vanacker, Fatma Guermazi, et al.
Pediatric Blood & Cancer|February 21, 2009
2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancerPerrine Marec-Berard, Pascal Chastagner, Diana Kassab-Chahmi, et al.
Bulletin Du Cancer|May 23, 2008
[Clinical Practice guidelines for the use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin bêta, darbepoetin) in anaemic patients with cancer: 2007 update (summary report)]Isabelle Ray-Coquard, Diana Kassab-Chahmi, Nicole Casadevall, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 10, 2018
Sexual desire of French representative prostate cancer survivors 2 years after diagnosis (the VICAN survey)Magali Girodet, Anne-Déborah Bouhnik, Julien Mancini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 6, 2008
[Standards & options: recommendations for the use of erythropoiesis-stimulating agents (ESA) in anaemic cancer patients undergoing radiotherapy (2007 update)]Christian Marchal, Jean-Louis Misset, Nicole Casadevall, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2016
Routine Clinical Practice for Patients With Recurrent Ovarian Carcinoma: Results From the TROCADERO StudyGilles Freyer, Isabelle Ray-Coquard, Dorothea Fischer, et al.
International Journal of Health Geographics|December 10, 2020
Beyond the map: evidencing the spatial dimension of health inequalitiesYohan Fayet, Delphine Praud, Béatrice Fervers, et al.
Bulletin Du Cancer|March 1, 2003
[Gastro-intestinal stromal tumors: news and comments]Isabelle Ray-Coquard, Axel Le Cesne, Véronique Michallet, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 17, 2019
Assessing the performance of indicators during their life cycle: the mixed QUID methodPhilippe Michel, Laurie Fraticelli, Pierre Parneix, et al.
Cancer Management and Research|December 29, 2010
New developments in treatment of ovarian carcinoma: focus on trabectedinPhilippe A Cassier, Aude Duret, Olivier Trédan, et al.
Pageof 63